Clinical trials
Completed Wilms Tumor trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
100 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 6 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 9 |
| 2007 | 6 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 100 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 20 |
| National Cancer Institute (NCI) | 19 |
| Fred Hutchinson Cancer Center | 10 |
| Memorial Sloan Kettering Cancer Center | 6 |
| National Institutes of Health Clinical Center (CC) | 4 |
| Emory University | 3 |
| M.D. Anderson Cancer Center | 3 |
| St. Jude Children's Research Hospital | 3 |
| Sumitomo Pharma America, Inc. | 3 |
| City of Hope Medical Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wilms Tumor | 100 |
| Neuroblastoma | 60 |
| Sarcoma | 45 |
| Osteosarcoma | 32 |
| Burkitt Lymphoma | 28 |
| Testicular Neoplasms | 28 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 26 |
| Dendritic Cell Sarcoma, Interdigitating | 25 |
| Kidney Neoplasms | 25 |
| Rhabdomyosarcoma | 25 |
Trials
Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.